Enzalutamide and Lung neoplasm malignant - a phase IV clinical study of FDA data

Summary:

Lung neoplasm malignant is reported as a side effect among people who take Enzalutamide (enzalutamide), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Micardis, and have Prostate cancer.

The phase IV clinical study analyzes which people have Lung neoplasm malignant when taking Enzalutamide. It is created by eHealthMe based on reports of 14,017 people who have side effects when taking Enzalutamide from the FDA, and is updated regularly.

What is Enzalutamide?

Enzalutamide has active ingredients of enzalutamide. eHealthMe is studying from 14,018 Enzalutamide users. Check the latest studies of Enzalutamide.

What is Lung neoplasm malignant?

Lung neoplasm malignant (cancer tumour of lung) is found to be associated with 1,149 drugs and 926 conditions by eHealthMe. Check the latest studies of Lung neoplasm malignant.

On Jul, 23, 2026

14,017 people reported to have side effects when taking Enzalutamide.
Among them, 15 people (0.11%) have Lung neoplasm malignant.

Could Enzalutamide cause Lung neoplasm malignant?

Among these 15 people:

How long have people been on Enzalutamide when they have Lung neoplasm malignant? *

What is the gender of people who have Lung neoplasm malignant when taking Enzalutamide? *

female: 0.0 %
male: 100 %

What is the age of people who have Lung neoplasm malignant when taking Enzalutamide? *

What are other drugs people take besides Enzalutamide? *

What are other side effects people have besides Lung neoplasm malignant? *

Electrocardiogram T Wave Inversion: 4 people, 26.67%
Adenocarcinoma (malignant tumour formed from glandular structures in epithelial tissue): 4 people, 26.67%
Intercostal Neuralgia (inflammation of the intercostal nerves): 3 people, 20.00%
Diverticulum Intestinal (a pouch that is attached to the first part of the small intestine): 3 people, 20.00%
Phrenic Nerve Paralysis: 3 people, 20.00%
Constipation: 3 people, 20.00%
Colon Cancer: 3 people, 20.00%
Death: 2 people, 13.33%
Prostatic Specific Antigen Increased: 2 people, 13.33%
Fatigue (feeling of tiredness): 2 people, 13.33%

What are the existing conditions these people have? *

Prostate Cancer: 6 people, 40.00%
High Blood Pressure: 5 people, 33.33%
Dermatitis Allergic (inflammation of the skin due allergic reaction): 4 people, 26.67%
Enlarged Prostate: 4 people, 26.67%
Clavicle Fracture: 2 people, 13.33%
Hepatic Function Abnormal: 1 person, 6.67%
Cataract (clouding of the lens inside the eye): 1 person, 6.67%
Constipation: 1 person, 6.67%
Gastritis (inflammation of stomach): 1 person, 6.67%
Glaucoma (increased fluid pressure in the eye with vision loss): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Enzalutamide and have Lung neoplasm malignant?

- Check whether Lung neoplasm malignant is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Enzalutamide:

Enzalutamide (14,018 reports)

Browse all side effects of Enzalutamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lung neoplasm malignant:

Lung neoplasm malignant (1,149 drugs)

Browse all the conditions that are associated with Lung neoplasm malignant:

Lung neoplasm malignant (926 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on enzalutamide (the active ingredients of Enzalutamide) and Enzalutamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.